Quarterly IID Change Log displays changes made since the previous quarterly IID publication.
Similar Posts
www.bigpharmausa.com – 702681 – 06/04/2025
Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the InternetFDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients
The U.S. Food and Drug Administration today established a “green list” import alert to help stop potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients (APIs) from unverified foreign sources from entering the U.S. market.Dr. Reddy’s Laboratories, LTD, Biologics – 09/12/2025
Dr. Reddy’s Laboratories, LTD, Biologics – 09/12/2025. Country: India. Record Type: 483FDA In Brief: FDA approves new packaging for brand-name over-the-counter loperamide to help curb abuse and misuse
FDA approves new packaging for brand-name over-the-counter loperamide to help curb abuse and misuseBulk Drug Substances Used in Compounding
Compounders sometimes produce drugs using bulk drug substances or active pharmaceutical ingredients. Because compounding from these substances presents risks to patients, sections 503A and 503B of the FD&C Act place limits on the bulk drug substances that can be used in compounding.Liquid Bicarbonate Concentrate Recall: Nipro Removes MedicaLyte Liquid Bicarbonate Concentrate due to Contamination
Nipro recalls bicarbonate dialysate concentrate due to contamination. Learn about potential serious injuries, fatality risks and essential steps for healthcare providers and patients for this Class I recall.